Palazzo, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 1.430
AS - Asia 854
EU - Europa 657
SA - Sud America 232
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 28
OC - Oceania 6
Totale 3.256
Nazione #
US - Stati Uniti d'America 1.373
IT - Italia 293
SG - Singapore 291
VN - Vietnam 197
BR - Brasile 189
CN - Cina 163
DE - Germania 76
IN - India 55
FR - Francia 51
SE - Svezia 49
FI - Finlandia 40
GB - Regno Unito 35
HK - Hong Kong 29
BD - Bangladesh 27
RU - Federazione Russa 22
CA - Canada 21
JP - Giappone 21
NL - Olanda 20
AR - Argentina 19
ID - Indonesia 17
IE - Irlanda 17
ZA - Sudafrica 11
MX - Messico 10
CO - Colombia 8
KR - Corea 8
BE - Belgio 7
EC - Ecuador 7
ES - Italia 7
IQ - Iraq 7
JM - Giamaica 7
PL - Polonia 7
AT - Austria 6
CI - Costa d'Avorio 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 4
IL - Israele 4
TR - Turchia 4
TT - Trinidad e Tobago 4
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
EE - Estonia 3
EG - Egitto 3
GT - Guatemala 3
IR - Iran 3
KE - Kenya 3
NP - Nepal 3
PK - Pakistan 3
PR - Porto Rico 3
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SV - El Salvador 2
TH - Thailandia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TV - Tuvalu 1
UA - Ucraina 1
UY - Uruguay 1
Totale 3.208
Città #
San Jose 207
Ashburn 187
Singapore 157
Rome 88
Ho Chi Minh City 73
Chicago 55
Hanoi 53
Los Angeles 52
Council Bluffs 50
Chandler 46
New York 41
Beijing 33
Milan 29
Hefei 28
Munich 28
São Paulo 28
Hyderabad 25
Buffalo 23
Phoenix 23
Lauterbourg 22
The Dalles 22
Frankfurt am Main 21
St Louis 21
Tokyo 21
Turku 21
Hong Kong 19
Dublin 15
Salt Lake City 14
Chennai 12
Helsinki 12
Santa Clara 12
Dallas 11
Orem 11
Genoa 10
Jakarta 10
North Bergen 10
Tampa 10
Düsseldorf 9
Haiphong 9
Rio de Janeiro 9
Brooklyn 8
Kent 8
Lancaster 8
Princeton 8
San Mateo 8
Seoul 8
Wilmington 8
Atlanta 7
Biên Hòa 7
Brussels 7
Denver 7
Elk Grove Village 7
Lappeenranta 7
London 7
Tukwila 7
Abidjan 6
Boardman 6
Can Tho 6
Mexico City 6
Miami 6
Moscow 6
Naples 6
Nuremberg 6
Porto Alegre 6
Toronto 6
Boston 5
Bremen 5
Catania 5
Dhaka 5
Johannesburg 5
Kingston 5
Las Vegas 5
Sterling 5
Tashkent 5
Ann Arbor 4
Bari 4
Belo Horizonte 4
City of London 4
Curitiba 4
Dulles 4
Kansas City 4
Madrid 4
Marseille 4
Montreal 4
Paris 4
Poplar 4
Sacramento 4
San Antonio 4
San Francisco 4
Tianjin 4
Vienna 4
Warsaw 4
Amsterdam 3
Baghdad 3
Betim 3
Chaguanas 3
Charlotte 3
Da Nang 3
Dammam 3
Fairfield 3
Totale 1.840
Nome #
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 343
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 211
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 203
Breast cancer drug approvals issued by EMA: A review of clinical trials 171
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 165
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 159
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response 156
Efficacy and safety of anakinra in radiation-induced acute pericarditis: a case report 151
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 146
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 143
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 141
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 135
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience 134
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 134
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 127
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 109
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 108
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication 97
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature 93
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors 80
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors) 73
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 61
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study 30
Predicting progression-free survival in hormone-receptor positive (HR+/HER2–) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors: A machine learning approach 29
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary Cohort 28
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study 20
Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study 9
Totale 3.256
Categoria #
all - tutte 11.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202261 0 0 0 0 0 9 0 10 1 2 23 16
2022/2023179 22 20 10 26 12 14 20 11 22 6 9 7
2023/2024147 12 20 6 6 4 36 16 14 3 4 12 14
2024/2025640 6 1 20 11 35 8 20 14 44 93 279 109
2025/20261.641 161 80 124 231 199 69 268 83 106 153 77 90
2026/2027588 72 110 182 214 10 0 0 0 0 0 0 0
Totale 3.256